Lisa Feng, DrPH is the Senior Director of Health Policy at Alexion, AstraZeneca Rare Disease which focuses on transforming the lives of people affected by rare diseases and devastating conditions. In her role at Alexion, Dr. Feng helps the company assess the evolving health policy landscape to lead efforts that help ensure patient access to current and future innovations. Prior to Alexion, Dr. Feng was Senior Director of Policy and Advocacy at the Cystic Fibrosis Foundation, where she led state and federal policy analysis and advocacy related to access to cystic fibrosis care and treatments. Dr. Feng was also responsible for the Value and Coverage program at FasterCures, a center of the Milken Institute. She has worked extensively on programs funded by the Center for Medicare and Medicaid Innovation and the Robert Wood Johnson Foundation. Dr. Feng is a health services researcher and has published on topics such as health care quality, diffusion of innovation, and health information technology. She received her doctorate in health policy at the George Washington University Milken Institute School of Public Health.
